Search - tctmd.com

Displaying 181 - 200 of 763

Sort: Relevancy | Date

Presentation TCT 2017

Desolve Nx, Cx, and Amity: A Family of Progressively Thinner-Strut PLLA-Based BRS With Novel Properties

Presenter: Bernard R. Chevalier, Corrado Tamburino, Stefan Verheye

October 31, 2017

Presentation TCT 2017

TRIGUARD Design Features and Clinical Findings From EU Clinical Trials

Presenter: Joachim Schofer

October 31, 2017

Presentation TCT 2017

State-of-the-Art Overview: Device-Based Therapies for CHF

Presenter: Daniel Burkhoff, JoAnn Lindenfeld

October 31, 2017

Presentation TCT 2017

Antithrombotic Therapy Considerations After TMVR: What Can We Learn From the Surgical Experience?

Presenter: Vinayak Bapat, Maurice Buchbinder

October 31, 2017

Presentation TCT 2017

DEBATE: Mechanical Hemodynamic Support in Cardiogenic Shock Should be Used Selectively!

Presenter: Michael Mooney, Holger Thiele, Jose P.S. Henriques

October 31, 2017

Presentation TCT 2017

WaveCrest: Device Description, Data, and Future Directions

Presenter: Mark Reisman, Josep Rodés-Cabau, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

Percutaneous Mechanical Support Devices: Current Uses and Unmet Clinical Needs

Presenter: David E. Kandzari, Jaime Raben, John C Laschinger

October 31, 2017

Presentation TCT 2017

LV Perforation After Transcatheter Mitral Valve Procedures: Frequency, Treatment Options, and Outcomes

Presenter: Vinayak Bapat, Maurice Buchbinder, Anita Asgar

October 31, 2017

Presentation TCT 2017

Do Some, All, or None of the Outcomes With the First Generation Absorb Scaffold Imply a Class Effect for All BRS? Educated Insights

Presenter: Bernard R. Chevalier, Corrado Tamburino, Yoshinobu Onuma

October 31, 2017

Presentation TCT 2017

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

Presenter: Jochen Wöhrle

October 31, 2017

Presentation TCT 2017

DEBATE: Mechanical Hemodynamic Support in Cardiogenic Shock Should be Used in All Patients!

Presenter: Michael Mooney, Holger Thiele, Tanveer Rab

October 31, 2017

Presentation TCT 2017

Ultraseal LAA Occluder: Device Description, Data, and Future Directions

Presenter: Mark Reisman, Josep Rodés-Cabau

October 31, 2017

Presentation TCT 2017

Paravalvular Leak and Hemolysis After TMVR: Incidence, Diagnosis, and Treatment

Presenter: Vinayak Bapat, Maurice Buchbinder, Carlos E. Ruiz

October 31, 2017

Presentation TCT 2017

Trial Design Considerations for Percutaneous Mechanical Support Devices: Necessity, Challenges, and Lessons Learned

Presenter: David E. Kandzari, Jaime Raben

October 31, 2017

Presentation TCT 2017

SENTINEL Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Presenter: Samir R. Kapadia

October 31, 2017

Presentation TCT 2017

Current State of Thoracic Branch Devices and Ongoing Clinical Trials

Presenter: Brian G. DeRubertis, Peter A. Schneider, Hiroo Takayama

October 31, 2017

Presentation TCT 2017

Mechanical Hemodynamic Support Should be Established Before Revascularization: Results From the US Impella Registry

Presenter: Michael Mooney, Holger Thiele, Brian P O'Neill

October 31, 2017

Presentation TCT 2017

Lambre: Device Description, Data, and Future Directions

Presenter: Mark Reisman, Josep Rodés-Cabau, Yat Sun Joseph Chan

October 31, 2017

Presentation TCT 2017

Frequency/Prevention/Treatment of LVOT Obstruction: Alcohol, Septal, Ablation, and LAMPOON

Presenter: Vinayak Bapat, Maurice Buchbinder, Jaffar M Khan

October 31, 2017

Presentation TCT 2017

Mechanical Hemodynamic Support: Counterpulsation, Rotary Flow, or ECMO for Cardiogenic Shock, and Why?

Presenter: Michael Mooney, Holger Thiele, Navin K. Kapur

October 31, 2017

Advertisement

Desolve Nx, Cx, and Amity: A Family of Progressively Thinner-Strut PLLA-Based BRS With Novel Properties

TRIGUARD Design Features and Clinical Findings From EU Clinical Trials

State-of-the-Art Overview: Device-Based Therapies for CHF

Antithrombotic Therapy Considerations After TMVR: What Can We Learn From the Surgical Experience?

DEBATE: Mechanical Hemodynamic Support in Cardiogenic Shock Should be Used Selectively!

WaveCrest: Device Description, Data, and Future Directions

Percutaneous Mechanical Support Devices: Current Uses and Unmet Clinical Needs

LV Perforation After Transcatheter Mitral Valve Procedures: Frequency, Treatment Options, and Outcomes

Do Some, All, or None of the Outcomes With the First Generation Absorb Scaffold Imply a Class Effect for All BRS? Educated Insights

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

DEBATE: Mechanical Hemodynamic Support in Cardiogenic Shock Should be Used in All Patients!

Ultraseal LAA Occluder: Device Description, Data, and Future Directions

Paravalvular Leak and Hemolysis After TMVR: Incidence, Diagnosis, and Treatment

Trial Design Considerations for Percutaneous Mechanical Support Devices: Necessity, Challenges, and Lessons Learned

SENTINEL Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Current State of Thoracic Branch Devices and Ongoing Clinical Trials

Mechanical Hemodynamic Support Should be Established Before Revascularization: Results From the US Impella Registry

Lambre: Device Description, Data, and Future Directions

Frequency/Prevention/Treatment of LVOT Obstruction: Alcohol, Septal, Ablation, and LAMPOON

Mechanical Hemodynamic Support: Counterpulsation, Rotary Flow, or ECMO for Cardiogenic Shock, and Why?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content